A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center.
Lisa CubaPauline DürrKatja GessnerBabette HäckerRainer FietkauJürgen SieblerMarianne PavelMarkus F NeurathCarola BerkingBernd WullichValeska BrücklMatthias W BeckmannMartin F FrommFrank DörjePublished in: JCO oncology practice (2024)
Despite not reaching the primary implementation outcome, the AMBORA Center included more treatment units and demonstrated patient benefit of the AMBORA care program by meeting all effectiveness outcomes. We outlined quantitative and qualitative implementation characteristics to enhance outreach and foster further dissemination of centers to optimize medication safety with OAT.
Keyphrases
- quality improvement
- healthcare
- primary care
- type iii
- systematic review
- randomized controlled trial
- palliative care
- adverse drug
- high resolution
- type diabetes
- adipose tissue
- pain management
- phase ii
- combination therapy
- insulin resistance
- skeletal muscle
- weight loss
- cell therapy
- health insurance
- open label
- replacement therapy
- double blind